We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Temodar and Sutent as Therapy for Melanoma

This study has been terminated.
(Funding was inadequate to continue; Companies requested closure.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00304200
First Posted: March 17, 2006
Last Update Posted: February 5, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Pfizer
Schering-Plough
Information provided by:
Northern California Melanoma Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2009
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)